Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2025

May 28, 2025

32044_dirs_2025-05-27_440ec066-dcf1-4d0d-a842-3859144c9454.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2025-05-23

Reporting Person: Sabzevari Helen (Director, President and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-23 Option to Purchase Common Stock (Right to Buy) $1.37 A 1000000 Acquired 2035-05-23 Common Stock (1000000) Direct

Footnotes

F1: The options vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter.